Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Distinct biological types of ocular adnexal sebaceous carcinoma: HPV-driven and virus-negative tumors arise through nonoverlapping molecular-genetic alterationsClinical Cancer Research.  25:1280-1290. 2019
2019 International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines from the Special Techniques and Ancillary Studies GroupInternational Journal of Gynecologic Pathology.  38:S114-S122. 2019
2018 Challenges in next generation sequencing analysis of somatic mutations in transplant patientsCancer Genetics.  226-227:17-22. 2018
2018 Gene expression analysis identifies novel targets for cervical cancer therapyFrontiers in Immunology.  9. 2018
2017 Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinomaJournal of Ovarian Research.  10. 2017
2017 Potential immunotherapy targets in recurrent cervical cancerGynecologic Oncology.  145:462-468. 2017
2017 Interobserver Reproducibility among Gynecologic Pathologists in Diagnosing Heterologous Osteosarcomatous Component in Gynecologic Tract CarcinosarcomasInternational Journal of Gynecologic Pathology.  36:386-392. 2017
2016 A unique presentation of acute liver failure from herpes simplex virus hepatitisTransplant Infectious Disease.  18:592-594. 2016
2016 Incidental Serous Tubal Intraepithelial Carcinoma and Non-Neoplastic Conditions of the Fallopian Tubes in Grossly Normal Adnexa: A Clinicopathologic Study of 388 Completely Embedded CasesInternational Journal of Gynecologic Pathology.  35:423-429. 2016
2016 Primary glial and neuronal tumors of the ovary or peritoneum a clinicopathologic study of 11 casesAmerican Journal of Surgical Pathology.  40:847-856. 2016
2015 Distribution and case-fatality ratios by cell-type for ovarian carcinomas: A 22-year series of 562 patients with uniform current histological classificationGynecologic Oncology.  136:336-340. 2015
2014 Basal cell carcinomas of the vulva: High-risk human papillomavirus DNA detection, p16 and BerEP4 expressionAmerican Journal of Surgical Pathology.  38:542-547. 2014
2014 Molecular alterations of PIK3CA in uterine carcinosarcoma, clear cell, and serous tumorsInternational Journal of Gynecological Cancer.  24:1262-1267. 2014
2014 Mucoepidermoid Carcinoma Does Not Harbor Transcriptionally Active High Risk Human Papillomavirus Even in the Absence of the MAML2 TranslocationHead and Neck Pathology.  8:298-302. 2014
2014 PAX8 expression in uterine adenocarcinomas and mesonephric proliferationsInternational Journal of Gynecologic Pathology.  33:492-499. 2014
2014 PAX8 expression in uterine malignant mesodermal mixed tumor (Carcinosarcoma)International Journal of Gynecologic Pathology.  33:425-431. 2014
2013 Clinically occult tubal and ovarian high-grade serous carcinomas presenting in uterine samples: Diagnostic pitfalls and clues to improve recognition of tumor originInternational Journal of Gynecologic Pathology.  32:433-443. 2013
2013 Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: Potential utility in diagnosis and managementModern Pathology.  26:268-274. 2013
2013 Coexisting High-grade Vulvar Intraepithelial Neoplasia (VIN) and Condyloma Acuminatum: Independent Lesions Due to Different HPV Types Occurring in Immunocompromised PatientsAmerican Journal of Surgical Pathology.  37:53-60. 2013
2013 Endocervical involvement in endometrial adenocarcinoma is not prognostically significant and the pathologic assessment of the pattern of involvement is not reproducibleGynecologic Oncology.  128:83-87. 2013
2012 Diagnostic reproducibility of hydatidiform moles: Ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis for both recently trained and experienced gynecologic pathologistsAmerican Journal of Surgical Pathology.  36:1747-1760. 2012
2012 Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinomaInternational Journal of Gynecologic Pathology.  31:243-253. 2012
2012 Diagnostic reproducibility of hydatidiform moles: Ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosisAmerican Journal of Surgical Pathology.  36:443-453. 2012
2012 Survival rates for International Federation of Gynecology and Obstetrics stage III ovarian carcinoma by cell type: A study of 262 unselected patients with uniform pathologic reviewInternational Journal of Gynecological Cancer.  22:367-371. 2012
2012 Stage I noninvasive and minimally invasive uterine serous carcinoma: Comprehensive staging associated with improved survivalInternational Journal of Gynecological Cancer.  22:273-279. 2012
2011 Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: An immunohistochemical and nucleotide sequencing analysisModern Pathology.  24:1248-1253. 2011
2011 Prevention of cancer by prophylactic human papillomavirus vaccinesCurrent Opinion in Immunology.  23:244-251. 2011
2011 "Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: Assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancerGynecologic Oncology.  120:470-473. 2011
2011 Ovarian metastases of pancreaticobiliary tract adenocarcinomas: Analysis of 35 cases, with emphasis on the ability of metastases to simulate primary ovarian mucinous tumorsAmerican Journal of Surgical Pathology.  35:276-288. 2011
2011 The fallopian tube-peritoneal junction: A potential site of carcinogenesisInternational Journal of Gynecologic Pathology.  30:4-11. 2011
2010 Upstaging pathologic stage i ovarian carcinoma based on dense adhesions is not warranted: A clinicopathologic study of 84 patients originally classified as FIGO stage IIGynecologic Oncology.  119:250-254. 2010
2010 Prognostic factors for stage i ovarian carcinomaInternational Journal of Gynecologic Pathology.  29:1-7. 2010
2009 Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: Immunohistochemical analysis of 201 casesAmerican Journal of Surgical Pathology.  33:1504-1514. 2009
2009 Defining the cut point between low-grade and high-grade ovarian serous carcinomas: A clinicopathologic and molecular genetic analysisAmerican Journal of Surgical Pathology.  33:1220-1224. 2009
2009 Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: Utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumorAmerican Journal of Surgical Pathology.  33:914-924. 2009
2009 Metastatic leiomyosarcoma diagnosed after uterine artery embolizationEuropean Journal of Gynaecological Oncology.  30:199-202. 2009
2009 Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2American Journal of Pathology.  174:136-143. 2009
2008 Endocervical adenocarcinomas with ovarian metastases: Analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasmsAmerican Journal of Surgical Pathology.  32:1835-1853. 2008
2008 Low-grade serous carcinoma of the ovary displaying a macropapillary pattern of invasionAmerican Journal of Surgical Pathology.  32:1800-1806. 2008
2008 Pathology of stage I versus stage III ovarian carcinoma with implications for pathogenesis and screeningInternational Journal of Gynecological Cancer.  18:465-469. 2008
2008 Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: Clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvementInternational Journal of Gynecologic Pathology.  27:182-190. 2008
2008 Distinction of primary and metastatic mucinous tumors involving the ovary: Analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classificationAmerican Journal of Surgical Pathology.  32:128-138. 2008
2007 Ovarian metastases of appendiceal tumors with goblet cell carcinoidlike and signet ring cell patterns: A report of 30 casesAmerican Journal of Surgical Pathology.  31:1502-1511. 2007
2007 p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: Utility for identification of metastatic HPV-related endocervical adenocarcinomasAmerican Journal of Surgical Pathology.  31:653-663. 2007
2006 Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: Comparison with CK20 and correlation with coordinate expression of CK7Modern Pathology.  19:1421-1428. 2006
2006 Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneumGynecologic Oncology.  103:703-708. 2006
2006 Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: Analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 casesAmerican Journal of Surgical Pathology.  30:1130-1139. 2006
2004 Venous Thrombosis in the Broad Ligament: Is it a Predictor of Postoperative Pulmonary Embolism in Gynecological Cancer Patients? A Case-control StudyInternational Journal of Gynecologic Pathology.  23:176-179. 2004

Education And Training

  • Doctor of Medicine in Molecular Medicine, Russian National Research Medical University named after N.I. Pirogov 1993
  • Washington Hospital Center Pathology, Residency 2005
  • Icahn School of Medicine at Mount Sinai Pathology, Postdoctoral Fellowship 2014
  • Full Name

  • Anna Yemelyanova